These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20443627)

  • 1. BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
    Wei J; Stebbins JL; Kitada S; Dash R; Placzek W; Rega MF; Wu B; Cellitti J; Zhai D; Yang L; Dahl R; Fisher PB; Reed JC; Pellecchia M
    J Med Chem; 2010 May; 53(10):4166-76. PubMed ID: 20443627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
    Wei J; Kitada S; Stebbins JL; Placzek W; Zhai D; Wu B; Rega MF; Zhang Z; Cellitti J; Yang L; Dahl R; Reed JC; Pellecchia M
    J Med Chem; 2010 Nov; 53(22):8000-11. PubMed ID: 21033669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
    Wei J; Kitada S; Rega MF; Stebbins JL; Zhai D; Cellitti J; Yuan H; Emdadi A; Dahl R; Zhang Z; Yang L; Reed JC; Pellecchia M
    J Med Chem; 2009 Jul; 52(14):4511-23. PubMed ID: 19555126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins.
    Wei J; Kitada S; Rega MF; Emdadi A; Yuan H; Cellitti J; Stebbins JL; Zhai D; Sun J; Yang L; Dahl R; Zhang Z; Wu B; Wang S; Reed TA; Wang HG; Lawrence N; Sebti S; Reed JC; Pellecchia M
    Mol Cancer Ther; 2009 Apr; 8(4):904-13. PubMed ID: 19372563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity.
    Dash R; Azab B; Quinn BA; Shen X; Wang XY; Das SK; Rahmani M; Wei J; Hedvat M; Dent P; Dmitriev IP; Curiel DT; Grant S; Wu B; Stebbins JL; Pellecchia M; Reed JC; Sarkar D; Fisher PB
    Proc Natl Acad Sci U S A; 2011 May; 108(21):8785-90. PubMed ID: 21555592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonists.
    Wei J; Rega MF; Kitada S; Yuan H; Zhai D; Risbood P; Seltzman HH; Twine CE; Reed JC; Pellecchia M
    Cancer Lett; 2009 Jan; 273(1):107-13. PubMed ID: 18782651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optically pure apogossypolone derivative as potent pan-active inhibitor of anti-apoptotic bcl-2 family proteins.
    Wei J; Stebbins JL; Kitada S; Dash R; Zhai D; Placzek WJ; Wu B; Rega MF; Zhang Z; Barile E; Yang L; Dahl R; Fisher PB; Reed JC; Pellecchia M
    Front Oncol; 2011; 1():28. PubMed ID: 22655238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).
    Kitada S; Kress CL; Krajewska M; Jia L; Pellecchia M; Reed JC
    Blood; 2008 Mar; 111(6):3211-9. PubMed ID: 18202226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-X(L).
    Becattini B; Kitada S; Leone M; Monosov E; Chandler S; Zhai D; Kipps TJ; Reed JC; Pellecchia M
    Chem Biol; 2004 Mar; 11(3):389-95. PubMed ID: 15123268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.
    Wang G; Nikolovska-Coleska Z; Yang CY; Wang R; Tang G; Guo J; Shangary S; Qiu S; Gao W; Yang D; Meagher J; Stuckey J; Krajewski K; Jiang S; Roller PP; Abaan HO; Tomita Y; Wang S
    J Med Chem; 2006 Oct; 49(21):6139-42. PubMed ID: 17034116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel water-soluble gossypol derivative increases chemotherapeutic sensitivity and promotes growth inhibition in colon cancer.
    Yan F; Cao XX; Jiang HX; Zhao XL; Wang JY; Lin YH; Liu QL; Zhang C; Jiang B; Guo F
    J Med Chem; 2010 Aug; 53(15):5502-10. PubMed ID: 20684596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia.
    Pan R; Ruvolo VR; Wei J; Konopleva M; Reed JC; Pellecchia M; Andreeff M; Ruvolo PP
    Blood; 2015 Jul; 126(3):363-72. PubMed ID: 26045609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer.
    Jackson RS; Placzek W; Fernandez A; Ziaee S; Chu CY; Wei J; Stebbins J; Kitada S; Fritz G; Reed JC; Chung LW; Pellecchia M; Bhowmick NA
    Neoplasia; 2012 Jul; 14(7):656-65. PubMed ID: 22904682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.
    Mohammad RM; Goustin AS; Aboukameel A; Chen B; Banerjee S; Wang G; Nikolovska-Coleska Z; Wang S; Al-Katib A
    Clin Cancer Res; 2007 Apr; 13(7):2226-35. PubMed ID: 17404107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening.
    Enyedy IJ; Ling Y; Nacro K; Tomita Y; Wu X; Cao Y; Guo R; Li B; Zhu X; Huang Y; Long YQ; Roller PP; Yang D; Wang S
    J Med Chem; 2001 Dec; 44(25):4313-24. PubMed ID: 11728179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor compounds identification from gossypol Groebke imidazopyridine product.
    Wang W; Lu Y; Chen E; Shen K; Li J
    Bioorg Chem; 2021 Sep; 114():105146. PubMed ID: 34328859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivo.
    Sun Y; Wu J; Aboukameel A; Banerjee S; Arnold AA; Chen J; Nikolovska-Coleska Z; Lin Y; Ling X; Yang D; Wang S; Al-Katib A; Mohammad RM
    Cancer Biol Ther; 2008 Sep; 7(9):1418-26. PubMed ID: 18769131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
    Lin J; Wu Y; Yang D; Zhao Y
    Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins.
    Zhai D; Jin C; Shiau CW; Kitada S; Satterthwait AC; Reed JC
    Mol Cancer Ther; 2008 Jun; 7(6):1639-46. PubMed ID: 18566235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.
    Meng Y; Tang W; Dai Y; Wu X; Liu M; Ji Q; Ji M; Pienta K; Lawrence T; Xu L
    Mol Cancer Ther; 2008 Jul; 7(7):2192-202. PubMed ID: 18645028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.